These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30465810)

  • 1. Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.
    Richter LHJ; Beck A; Flockerzi V; Maurer HH; Meyer MR
    Toxicol Lett; 2019 Feb; 301():79-89. PubMed ID: 30465810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds.
    Gampfer TM; Wagmann L; Pulver B; Westphal F; Flockerzi V; Meyer MR
    Toxicology; 2022 Jun; 476():153258. PubMed ID: 35842060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.
    Luethi D; Liechti ME; Krähenbühl S
    Toxicology; 2017 Jul; 387():57-66. PubMed ID: 28645576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?
    Ford LT; Berg JD
    Ann Clin Biochem; 2017 Mar; 54(2):219-229. PubMed ID: 27166311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay.
    Gampfer TM; Schütz V; Schippers P; Rasheed S; Baumann J; Wagmann L; Pulver B; Westphal F; Flockerzi V; Müller R; Meyer MR
    J Pharm Biomed Anal; 2024 Aug; 245():116187. PubMed ID: 38692215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems.
    Gampfer TM; Wagmann L; Belkacemi A; Flockerzi V; Meyer MR
    Arch Toxicol; 2021 Nov; 95(11):3539-3557. PubMed ID: 34453555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples.
    Richter LHJ; Flockerzi V; Maurer HH; Meyer MR
    J Pharm Biomed Anal; 2017 Sep; 143():32-42. PubMed ID: 28601767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation.
    Di Rago M; Chu M; Rodda LN; Jenkins E; Kotsos A; Gerostamoulos D
    Anal Bioanal Chem; 2016 May; 408(14):3737-49. PubMed ID: 26993306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
    Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
    J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.
    Caspar AT; Meyer MR; Westphal F; Weber AA; Maurer HH
    Talanta; 2018 Oct; 188():111-123. PubMed ID: 30029353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effects of fructose and N-acetyl-L-cysteine against cytotoxicity induced by the psychoactive compounds N-methyl-5-(2-aminopropyl)benzofuran and 3,4-methylenedioxy-N-methamphetamine in isolated rat hepatocytes.
    Nakagawa Y; Suzuki T; Inomata A
    J Appl Toxicol; 2018 Feb; 38(2):284-291. PubMed ID: 28949027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples.
    Salomone A; Gazzilli G; Di Corcia D; Gerace E; Vincenti M
    Anal Bioanal Chem; 2016 Mar; 408(8):2035-42. PubMed ID: 26680593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
    Nakagawa Y; Suzuki T; Tayama S; Ishii H; Ogata A
    Arch Toxicol; 2009 Jan; 83(1):69-80. PubMed ID: 18553070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the stability of emerging new psychoactive substances.
    Soh YN; Elliott S
    Drug Test Anal; 2014; 6(7-8):696-704. PubMed ID: 24573920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New psychoactive substances: Studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-α-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations in comparison to primary human hepatocytes, and human urine.
    Richter LHJ; Maurer HH; Meyer MR
    Toxicol Lett; 2017 Oct; 280():142-150. PubMed ID: 28782580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project.
    Bäckberg M; Lindeman E; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Jan; 53(1):46-53. PubMed ID: 25422862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes - A comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvae.
    Richter LHJ; Herrmann J; Andreas A; Park YM; Wagmann L; Flockerzi V; Müller R; Meyer MR
    Toxicol Lett; 2019 May; 305():73-80. PubMed ID: 30682400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
    Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
    Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.